Nuveen Asset Management, LLC Novo Cure LTD Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 364,553 shares of NVCR stock, worth $11.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

364,553

Previous 443,699 17.84%

Holding current value

$11.6 Million

Previous $7.6 Million 25.04%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.61 - $23.34 $1.24 Million - $1.85 Million	-79,146 Reduced 17.84%	364,553 $5.7 Million
Q2 2024 Aug 09, 2024	BUY	$11.83 - $24.05 $1.83 Million - $3.72 Million	154,590 Added 53.47%	443,699 $7.6 Million
Q1 2024 May 13, 2024	SELL	$12.42 - $17.29 $292,739 - $407,525	-23,570 Reduced 7.54%	289,109 $4.52 Million
Q4 2023 Feb 14, 2024	SELL	$11.13 - $15.78 $177,868 - $252,180	-15,981 Reduced 4.86%	312,679 $4.67 Million
Q3 2023 Nov 14, 2023	BUY	$16.15 - $42.35 $515,088 - $1.35 Million	31,894 Added 10.75%	328,660 $5.31 Million
Q2 2023 Aug 14, 2023	SELL	$40.29 - $82.51 $185,978 - $380,866	-4,616 Reduced 1.53%	296,766 $12.3 Million
Q1 2023 May 15, 2023	SELL	$56.44 - $118.81 $21,165 - $44,553	-375 Reduced 0.12%	301,382 $18.1 Million
Q4 2022 Feb 14, 2023	SELL	$63.98 - $85.37 $3.98 Million - $5.32 Million	-62,259 Reduced 17.1%	301,757 $22.1 Million
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $695,129 - $915,763	10,224 Added 2.89%	364,016 $27.7 Million
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $375,427 - $596,306	-6,633 Reduced 1.84%	353,792 $24.6 Million
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $17,804 - $25,017	-296 Reduced 0.08%	360,425 $28.3 Million
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $3 Million - $4.87 Million	-39,907 Reduced 9.96%	360,721 $27.1 Million
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $10.5 Million - $17.5 Million	-90,203 Reduced 18.38%	400,628 $46.5 Million
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $2.61 Million - $4.52 Million	20,043 Added 4.26%	490,831 $109 Million
Q1 2021 May 17, 2021	SELL	$124.11 - $190.17 $2.14 Million - $3.28 Million	-17,269 Reduced 3.54%	470,788 $62.2 Million
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $14.9 Million - $23.2 Million	133,149 Added 37.52%	488,057 $84.5 Million
Q3 2020 Nov 16, 2020	BUY	$58.05 - $111.31 $6.27 Million - $12 Million	108,073 Added 43.78%	354,908 $39.5 Million
Q2 2020 Aug 14, 2020	SELL	$57.2 - $74.41 $18.2 Million - $23.7 Million	-318,704 Reduced 56.35%	246,835 $14.6 Million
Q1 2020 May 14, 2020	BUY	$57.05 - $95.75 $4.98 Million - $8.36 Million	87,328 Added 18.26%	565,539 $38.1 Million
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $463,415 - $636,433	-6,785 Reduced 1.4%	478,211 $40.3 Million
Q3 2019 Nov 14, 2019	SELL	$61.86 - $97.8 $1.43 Million - $2.27 Million	-23,176 Reduced 4.56%	484,996 $36.3 Million
Q2 2019 Aug 15, 2019	BUY	$42.22 - $63.23 $20.4 Million - $30.6 Million	483,912 Added 1994.69%	508,172 $30.9 Million
Q1 2019 May 14, 2019	SELL	$31.96 - $56.12 $6.95 Million - $12.2 Million	-217,468 Reduced 89.96%	24,260 $1.17 Million
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $4.97 Million - $9.11 Million	-173,182 Reduced 41.74%	241,728 $8.09 Million
Q3 2018 Nov 13, 2018	SELL	$32.0 - $52.4 $696,800 - $1.14 Million	-21,775 Reduced 4.99%	414,910 $21.7 Million
Q2 2018 Aug 14, 2018	BUY	$19.85 - $32.0 $2.74 Million - $4.42 Million	138,257 Added 46.33%	436,685 $13.7 Million
Q1 2018 May 14, 2018	BUY	$19.3 - $23.65 $5.76 Million - $7.06 Million	298,428 New	298,428 $6.51 Million

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.33B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Novo Cure LTD Transaction History